🇺🇸 FDA
Pipeline program

Tofacitinib with methotrexate

A3921187

Approved small_molecule completed

Quick answer

Tofacitinib with methotrexate for Rhematoid Arthritis is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).

Program details

Company
Pfizer
Indication
Rhematoid Arthritis
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials